TRVI Trevi Therapeutics, Inc.

Fundamentals / CIK 0001563880 / USD

Trevi Therapeutics, Inc. reported $310.8M in total assets and a net loss of $60.76M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TRVI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2018 to 2025), reported in USD.

$0$0$0-$44.80MFY 2018 Net Income: -$20.55M2018FY 2019 Net Income: -$26.05M2019FY 2020 Net Income: -$32.76M2020FY 2021 Net Income: -$33.94M2021FY 2022 Net Income: -$29.15M2022FY 2023 Net Income: -$29.07M2023FY 2024 Net Income: -$47.91M2024FY 2025 Net Income: -$42.76M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $33.48M $39.38M $23.68M $19.83M $22.98M $22.33M $19.34M $14.07M
Total Operating Expenses $49.33M $51.52M $33.92M $29.91M $32.48M $32.49M $26.64M $18.41M
Operating Income -$49.33M -$51.52M -$33.92M -$29.91M -$32.48M -$32.49M -$26.64M -$18.41M
EBITDA -$49.18M -$51.38M -$33.80M -$29.86M -$32.43M -$32.44M -$26.61M -$18.39M
Interest Income $6.54M $3.60M $4.75M -- -- -- -- --
Interest Expense $0 $4.0K $391K $1.16M $1.20M $456K -- $174K
Income Before Tax -$42.82M -$47.94M -$29.10M -$29.19M -$33.96M -$32.78M -$26.07M -$20.67M
Income Tax Expense -$64K -$30K -$32K -$36K -$21K -$18K -$18K -$124K
Net Income -$42.76M -$47.91M -$29.07M -$29.15M -$33.94M -$32.76M -$26.05M -$20.55M
Basic EPS -$0.32 -$0.47 -$0.29 -$0.45 -$1.49 -$1.81 -$2.28 -$58.44
Diluted EPS -$0.32 -$0.47 -$0.29 -$0.45 -$1.49 -$1.81 -$2.28 -$58.44
Basic Shares Outstanding 134.7M 102.0M 99.0M 64.5M 22.8M 18.1M 11.7M 437.6K
Diluted Shares Outstanding 134.7M 102.0M 99.0M 64.5M 22.8M 18.1M 11.7M 437.6K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $19.06M $15.15M $9.94M $6.19M $10.09M $9.39M $7.81M $9.33M
Total Operating Expenses $24.49M $20.51M $14.91M $10.22M $13.92M $13.72M $11.47M $12.24M
Operating Income -$24.49M -$20.51M -$14.91M -$10.22M -$13.92M -$13.72M -$11.47M -$12.24M
EBITDA -$24.45M -$20.48M -$14.88M -$10.19M -$13.88M -$13.68M -$11.43M -$12.21M
Interest Income $3.02M $2.70M $1.70M $1.90M $2.10M $1.41M $1.12M $843K
Interest Expense -- -- -- -- $0 $0 -- $1.0K
Income Before Tax -$21.47M -$17.82M -$13.21M -$8.33M -$11.82M -$12.32M -$10.35M -$11.40M
Income Tax Expense -$19K -$19K -$20K -$16K -$15K -$21K -$11K $16K
Net Income -$21.45M -$17.80M -$13.19M -$8.32M -$11.80M -$12.30M -$10.34M -$11.41M
Basic EPS -$0.13 -$0.11 -$0.09 -- -$0.08 -$0.09 -$0.09 --
Diluted EPS -$0.13 -$0.11 -$0.09 -- -$0.08 -$0.09 -$0.09 --
Basic Shares Outstanding 159.7M 156.6M 145.6M -- 145.1M 130.4M 117.6M --
Diluted Shares Outstanding 159.7M 156.6M 145.6M -- 145.1M 130.4M 117.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $18.91M $34.10M $32.40M $12.59M $36.83M $45.00M $57.31M $7.20M
Short-Term Investments $169.3M $73.53M $50.57M $107.9M -- -- -- --
Cash & Short-Term Investments $188.3M $107.6M $82.97M $120.5M $36.83M $45.00M $57.31M $7.20M
Other Current Assets $2.13M $867K $955K $1.31M $241K $265K -- --
Total Current Assets $191.7M $109.4M $87.55M $122.6M $37.96M $46.27M $59.55M $8.82M
Property, Plant & Equipment, Net $178K $157K $216K $170K $53K $103K $118K $149K
Other Non-Current Assets $928K $243K $297K $205K $334K $532K -- --
Total Non-Current Assets $1.78M $1.47M $1.86M $399K $518K $862K $449K $1.70M
Total Assets $193.4M $110.9M $89.40M $123.0M $38.48M $47.13M $60.00M $10.53M
Accounts Payable $3.91M $3.41M $1.81M $2.86M $2.85M $2.02M $1.60M $603K
Total Current Liabilities $9.75M $10.51M $5.82M $13.40M $12.72M $5.55M $5.20M $2.68M
Other Non-Current Liabilities -- -- -- $3.0K -- -- -- --
Total Non-Current Liabilities $446K $747K $1.03M $2.16M $8.68M $14.29M $257K $117.3M
Total Liabilities $10.20M $11.26M $6.86M $15.56M $21.40M $19.85M $5.46M $120.0M
Total Debt (incl. Leases) $753K $1.03M $1.34M $27K $144K $257K $356K $46K
Common Stock $128K $94K $68K $60K $29K $19K $18K $4.0K
Retained Earnings -$329.8M -$287.0M -$239.1M -$210.1M -$180.9M -$147.0M -$114.2M -$109.5M
Accumulated Other Comp. Income $148K $61K -$29K -$122K -- -- -- --
Total Stockholders' Equity $183.2M $99.64M $82.55M $107.5M $17.07M $27.28M $54.55M -$109.5M
Total Equity $183.2M $99.64M $82.55M $107.5M $17.07M $27.28M $54.55M -$109.5M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $27.85M $54.30M $19.41M $18.91M $56.87M $117.1M $19.37M $34.10M
Short-Term Investments $271.6M $264.6M $152.4M $169.3M $138.1M $86.83M $83.88M $73.53M
Cash & Short-Term Investments $299.4M $318.9M $171.8M $188.3M $194.9M $203.9M $103.3M $107.6M
Other Current Assets $2.81M $2.57M $2.12M $2.13M $2.00M $1.58M $834K $867K
Total Current Assets $305.8M $325.7M $176.1M $191.7M $198.3M $207.2M $105.6M $109.4M
Property, Plant & Equipment, Net $342K $336K $265K $178K $213K $239K $277K $157K
Other Non-Current Assets $4.20M $3.94M $2.61M $928K $103K $68K $241K $243K
Total Non-Current Assets $5.01M $4.81M $3.48M $1.78M $1.06M $1.11M $1.38M $1.47M
Total Assets $310.8M $330.5M $179.6M $193.4M $199.4M $208.3M $107.0M $110.9M
Accounts Payable $1.51M $3.10M $2.21M $3.91M $2.71M $2.97M $1.42M $3.41M
Total Current Liabilities $7.87M $8.74M $7.12M $9.75M $9.04M $9.24M $6.87M $10.51M
Total Non-Current Liabilities $187K $276K $364K $446K $527K $605K $681K $747K
Total Liabilities $8.06M $9.01M $7.48M $10.20M $9.57M $9.85M $7.55M $11.26M
Total Debt (incl. Leases) $527K $605K $682K $753K $823K $891K $957K $1.03M
Common Stock $143K $142K $128K $128K $128K $122K $100K $94K
Retained Earnings -$382.2M -$360.8M -$343.0M -$329.8M -$321.5M -$309.7M -$297.4M -$287.0M
Accumulated Other Comp. Income -$1.50M -$425K -$190K $148K $30K $24K $73K $61K
Total Stockholders' Equity $302.8M $321.5M $172.1M $183.2M $189.8M $198.5M $99.46M $99.64M
Total Equity $302.8M $321.5M $172.1M $183.2M $189.8M $198.5M $99.46M $99.64M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$42.76M -$47.91M -$29.07M -$29.15M -$33.94M -$32.76M -$26.05M -$20.55M
Depreciation & Amortization $144K $147K $123K $43K $50K $47K $39K $23K
Stock-Based Compensation $5.18M $3.59M $2.25M $2.33M $2.54M $2.42M $1.13M $496K
Change in Receivables -- -- -- -- -- -- -$374K -$135K
Change in Payables -$598K $1.60M -$1.05M $9.0K $831K $417K $777K $66K
Operating Cash Flow -$42.09M -$38.26M -$31.71M -$28.18M -$28.95M -$29.00M -$23.09M -$18.29M
Capital Expenditure -$12K -$35K -$137K -$159K -- -$32K -$9.0K -$158K
Free Cash Flow -$42.10M -$38.29M -$31.85M -$28.33M -- -$29.03M -$23.10M -$18.45M
Purchases of Investments -$170.7M -$98.46M -$9.93M -$126.2M -- -- -- --
Investing Cash Flow -$94.11M -$21.53M $59.43M -$107.4M -- -$32K -$9.0K -$158K
Financing Cash Flow $121.0M $61.48M -$7.91M $111.3M $20.77M $16.72M $73.21M $3.63M
Net Change in Cash -$15.18M $1.70M $19.81M -$24.24M -$8.17M -$12.31M $50.11M -$14.82M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$21.45M -$17.80M -$13.19M -$8.32M -$11.80M -$12.30M -$10.34M -$11.41M
Depreciation & Amortization $41K $34K $34K $31K $38K $38K $37K $38K
Stock-Based Compensation $3.37M $3.27M $2.19M $1.35M $1.24M $1.38M $1.21M $917K
Change in Payables -$451K -$276K -$1.48M $123K -$282K $1.55M -$1.99M $1.80M
Operating Cash Flow -$19.69M -$17.43M -$16.69M -$7.63M -$10.88M -$10.10M -$13.48M -$9.55M
Capital Expenditure -$25K -$124K -$102K -- -- -- -- --
Free Cash Flow -$19.71M -$17.55M -$16.79M -- -- -- -- --
Purchases of Investments -$47.49M -$153.6M -$8.48M -$54.40M -$71.61M -$17.11M -$27.55M -$45.19M
Investing Cash Flow -$7.18M -$112.0M $16.96M -$30.61M -$50.94M -$2.61M -$9.95M -$23.87M
Financing Cash Flow $412K $164.4M $222K $284K $1.63M $110.4M $8.71M $51.47M
Net Change in Cash -$26.45M $34.89M $498K -$37.95M -$60.19M $97.68M -$14.72M $18.05M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -23.3% -48.1% -35.2% -27.1% -198.8% -120.1% -47.8% --
Return on Assets (ROA) -22.1% -43.2% -32.5% -23.7% -88.2% -69.5% -43.4% -195.2%
Current Ratio 19.66x 10.41x 15.03x 9.15x 2.98x 8.33x 11.45x 3.30x
Quick Ratio 19.31x 10.24x 14.25x 8.99x 2.89x 8.10x 11.02x 2.69x
Debt to Equity 0.00x 0.01x 0.02x 0.00x 0.01x 0.01x 0.01x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -20.1% -15.9% -26.5% -23.3% -24.2% -23.8% -47.6% -48.1%
Return on Assets (ROA) -19.5% -15.5% -25.4% -22.1% -23.0% -22.7% -44.2% -43.2%
Current Ratio 38.86x 37.28x 24.75x 19.66x 21.93x 22.42x 15.38x 10.41x
Quick Ratio 38.05x 36.50x 24.14x 19.31x 21.56x 22.06x 15.04x 10.24x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.01x 0.01x
Source: SEC EDGAR CompanyFacts (CIK 0001563880) · from March 31, 2018 Data through September 30, 2026 · synced Nov 20, 2026, 05:23 UTC · Open in terminal